BGBIO — Bergenbio ASA Income Statement
0.000.00%
Last trade - 00:00- NOK68.95m
- -NOK70.39m
- NOK0.85m
- 12
- 20
- 53
- 15
Annual income statement for Bergenbio ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.601 | 0.774 | 0.389 | 0.354 | 0.848 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 262 | 315 | 306 | 192 | 152 |
| Operating Profit | -261 | -314 | -306 | -192 | -151 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -257 | -309 | -302 | -190 | -139 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -257 | -309 | -302 | -190 | -139 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -257 | -309 | -302 | -190 | -139 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -257 | -309 | -302 | -190 | -139 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -39.4 | -40.4 | -39.1 | -13.3 | -3.95 |